Dermatology TextbookGenerating differential diagnosisPart C Differential Diagnosis

Differential Diagnosis of Sclerosis

Introduction

Sclerosis refers to pathological induration or hardening of the skin due to excessive collagen deposition or alteration in the dermal connective tissue. The skin becomes thickened, taut, and bound down. Recognizing sclerotic conditions is critical as they may represent localized skin disease (morphea) or manifestations of life-threatening systemic disease (systemic sclerosis).


39.1 Classification of Sclerotic Conditions

39.1.1 Localized Scleroderma (Morphea)

  • Definition: Localized fibrosis of the skin without systemic involvement.
  • Epidemiology: More common in women. Peak in childhood and 40-50 years.
  • Variants:
    • Plaque Morphea: Most common. One or few oval plaques on trunk.
    • Linear Morphea: Linear band, often on extremity or forehead ("en coup de sabre"). May affect underlying muscle/bone.
    • Generalized Morphea: ≥4 plaques involving ≥2 body areas.
    • Pansclerotic Morphea: Severe, affecting entire limb circumferentially. Can be disabling.
    • Deep Morphea: Involves subcutis, fascia, or muscle.
  • Clinical Features:
    • Early (Inflammatory): Erythematous or violaceous border ("Lilac ring").
    • Established: Ivory-white, waxy, indurated center. Bound-down skin.
    • Late: Hyperpigmentation or hypopigmentation, atrophy.
  • Diagnosis: Clinical. Skin biopsy shows collagen thickening.
  • Prognosis: Usually self-limited (3-5 years). Does NOT progress to systemic sclerosis.

39.1.2 Systemic Sclerosis (Scleroderma)

  • Definition: Multisystem autoimmune disease characterized by vascular dysfunction, immune activation, and fibrosis of skin and internal organs.
  • Epidemiology: Female predominance (4:1). Peak 30-50 years.
  • Subtypes:
FeatureLimited Cutaneous SSc (lcSSc)Diffuse Cutaneous SSc (dcSSc)
Skin InvolvementDistal to elbows/knees + FaceTrunk + Proximal limbs
Raynaud'sPrecedes skin changes by yearsConcurrent with skin changes
Internal OrgansPAH late, GIEarly pulmonary fibrosis (ILD), Renal crisis
AntibodiesAnti-centromere (ACA)Anti-Scl70 (Anti-topoisomerase I)
CRESTCalcinosis, Raynaud's, Esophageal dysmotility, Sclerodactyly, Telangiectasia-
PrognosisBetterWorse
  • Skin Features:
    • Raynaud's Phenomenon: Often first sign. Triphasic color change (White→Blue→Red).
    • Sclerodactyly: Skin tightening of fingers.
    • Digital Ulcers/Pits: On fingertips, over bony prominences.
    • Mat-like Telangiectasias: Face, lips, hands.
    • Calcinosis Cutis: Calcium deposits in skin.
    • Facial Changes: Reduced oral aperture (microstomia), perioral furrowing.
  • Nail Fold Capillaroscopy: Dilated capillary loops with dropout (megacapillaries).
  • Diagnosis: Clinical + Autoantibodies + Nail fold capillaroscopy.

39.1.3 Eosinophilic Fasciitis (Shulman Syndrome)

  • Definition: Rare inflammatory condition causing sclerosis of deep fascia.
  • Trigger: Often follows strenuous physical exertion.
  • Clinical Features:
    • Rapid onset of symmetric limb swelling and induration.
    • "Peau d'orange" (orange peel skin) and "Groove sign" (depression along superficial veins due to fascial tethering).
    • Spares hands and feet (unlike SSc).
  • Lab: Peripheral eosinophilia. Elevated ESR.
  • Diagnosis: Full-thickness biopsy (skin to muscle) showing fascial thickening and eosinophilic infiltrate.
  • Treatment: Systemic corticosteroids.

39.1.4 Nephrogenic Systemic Fibrosis (NSF)

  • Setting: Patients with severe renal impairment (CKD stage 4-5, dialysis) exposed to gadolinium-based contrast agents (MRI).
  • Clinical Features:
    • Symmetric skin thickening and fibrosis, starting from legs.
    • "Woody" texture.
    • Papules, nodules, plaques.
    • Joint contractures.
    • May involve internal organs (muscle, heart, lungs).
  • Prognosis: Variable. Can be disabling or fatal.
  • Prevention: Avoid gadolinium in severe CKD. Use macrocyclic agents if needed.

39.1.5 Sclerodermoid Graft-versus-Host Disease (GVHD)

  • Setting: Chronic GVHD post-allogeneic stem cell transplant.
  • Features: Lichenoid changes → Sclerotic changes mimicking morphea or systemic sclerosis.
  • Distribution: Variable.

39.1.6 Scleredema

  • Definition: Diffuse, non-pitting induration of upper back and neck.
  • Subtypes:
    • Scleredema Adultorum of Buschke: Post-infectious (Streptococcal). Self-limited.
    • Scleredema Diabeticorum: Associated with long-standing, poorly controlled diabetes. Persistent.
    • Paraproteinemia-Associated: Associated with myeloma.

39.1.7 Scleromyxedema (Papular Mucinosis)

  • Definition: Generalized papular and sclerodermiform mucinosis associated with paraproteinemia (IgG lambda).
  • Clinical Features:
    • Waxy papules and plaques.
    • Sclerosis and induration.
    • "Leonine facies".
  • Serious Condition: Can affect CNS, GI, Heart.

39.2 Diagnostic Algorithm

Loading diagram...

39.3 Summary Comparison Table

ConditionDistributionKey FeaturesAssociations
MorpheaLocalized plaquesLilac ring, Ivory centerLocalized, No systemic
Limited SSc (CREST)Distal to elbow/kneeRaynaud's, Sclerodactyly, PAHAnti-centromere
Diffuse SScTrunk, ProximalRapid onset, ILD, Renal crisisAnti-Scl70
Eosinophilic FasciitisLimbs (spares hands)Groove sign, Peau d'orangeEosinophilia
NSFLegs → GeneralizedGadolinium, CKD, Woody texturePost-MRI contrast
ScleredemaUpper back, NeckNon-pitting, StiffDM, Strep, Myeloma

39.4 Clinical Pearls

  1. Localized sclerosis with lilac ring → Morphea. Does NOT progress to systemic sclerosis.
  2. Raynaud's + Sclerodactyly + Telangiectasias → Systemic sclerosis. Screen for PAH (lcSSc) or ILD (dcSSc).
  3. Groove sign + Limb induration + Eosinophilia → Eosinophilic fasciitis. Deep biopsy needed.
  4. CKD patient + Post-MRI + Woody skin → NSF. Avoid gadolinium in severe CKD.
  5. Upper back induration + Diabetes → Scleredema diabeticorum.
  6. Nail fold capillaroscopy: Megacapillaries with dropout = Systemic sclerosis or Dermatomyositis.

How to Cite

Cutisight. "Sclerosis." Encyclopedia of Dermatology [Internet]. 2026. Available from: https://cutisight.com/education/volume-04-generating-differential-diagnosis/part-c-differential-diagnosis/39-sclerosis

This is an open-access resource. Please cite appropriately when using in academic or clinical work.